BLISS GVS PHARMA
|
BLISS GVS PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹190 Cr | ₹126 Cr | ₹146 Cr | ₹106 Cr | ₹128 Cr |
| Adjustment | ₹96 Cr | ₹71 Cr | ₹38 Cr | ₹58 Cr | ₹-32 Cr |
| Changes In working Capital | ₹-104 Cr | ₹-51 Cr | ₹-47 Cr | ₹-85 Cr | ₹73 Cr |
| Cash Flow after changes in Working Capital | ₹181 Cr | ₹145 Cr | ₹138 Cr | ₹79 Cr | ₹169 Cr |
| Cash Flow from Operating Activities | ₹139 Cr | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr |
| Cash Flow from Investing Activities | ₹-38 Cr | ₹-76 Cr | ₹-83 Cr | ₹-7.75 Cr | ₹-93 Cr |
| Cash Flow from Financing Activities | ₹-89 Cr | ₹-30 Cr | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr |
| Net Cash Inflow / Outflow | ₹11 Cr | ₹0.13 Cr | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr |
| Opening Cash & Cash Equivalents | ₹24 Cr | ₹24 Cr | ₹25 Cr | ₹22 Cr | ₹13 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹0.10 Cr | ₹0.10 Cr | ₹-0.15 Cr | ₹1.40 Cr | ₹-9.92 Cr |
| Closing Cash & Cash Equivalent | ₹35 Cr | ₹24 Cr | ₹24 Cr | ₹25 Cr | ₹22 Cr |
Compare Cashflow Statement of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹5,561.7 Cr | 3.5% | 24.5% | 228.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3.5% |
24.5% |
228.3% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses